Douglas A. Lauffenburger
Direktor/Vorstandsmitglied bei Torque Therapeutics, Inc.
Profil
Douglas A.
Lauffenburger is currently the Director at Torque Therapeutics, Inc. He is also a Member at Massachusetts Institute of Technology and National Cancer Institute.
Previously, he was a Director at Selventa, Inc. Lauffenburger received his undergraduate degree from the University of Illinois and his doctorate from the University of Minnesota.
Aktive Positionen von Douglas A. Lauffenburger
| Unternehmen | Position | Beginn |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.01.2016 |
Ehemalige bekannte Positionen von Douglas A. Lauffenburger
| Unternehmen | Position | Ende |
|---|---|---|
Selventa, Inc.
 Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Douglas A. Lauffenburger
| University of Illinois | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Selventa, Inc.
Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Health Technology |
